PillRx only · Injection · Intramuscular
Lorazepam
Brands: Ativan · Lorazepam
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers4 labelers
Packages17
DEA / ScheduleCIV
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.925
Latest avg · Jun 17, 2026
+77%
Since Apr 23, 2025
4
Active US suppliers
88%
Top-2 supplier share*
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 13 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Civica, Inc. | unknown | 1 | SUPPLYING |
| International Medication Systems, Limited | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.